Pantherna Therapeutics

About:

Pantherna Therapeutics is a privately-held biopharmaceutical company.

Website: https://pantherna-therapeutics.com/

Top Investors: European Investment Fund, HTGF | High-Tech Gruenderfonds, Detlev Riesner

Description:

Pantherna Therapeutics is a privately-held biopharmaceutical Company developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative technology platform is based on advanced nanoparticles for the delivery and expression of therapeutic mRNA drugs in the endothelium. Pantherna is based in Hennigsdorf (Brandenburg) close to Berlin, Germany.

Total Funding Amount:

3.5M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Hennigsdorf, Brandenburg, Germany

Founded Date:

2017-01-01

Contact Email:

contact(AT)pantherna-therapeutics.com

Founders:

Klaus Giese

Number of Employees:

11-50

Last Funding Date:

2019-07-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai